TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
3H Biomedical AB
Closing information (x1000 EUR)
| Closing information | 2025/08 | 2024/08 | 2023/08 |
| Turnover |
320
|
255
|
367 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
8
|
-35
|
67 |
| EBITDA |
7
|
-34
|
69 |
| Total assets |
296
|
293
|
287 |
| Current assets |
291
|
286
|
278 |
| Current liabilities |
169
|
151
|
61 |
| Equity capital |
128
|
137
|
209 |
| - share capital |
9
|
9
|
8 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Solvency |
43.2%
|
46.8%
|
72.8% |
| Turnover per employee |
160
|
128
|
184 |
| Profit as a percentage of turnover |
2.5%
|
-13.7%
|
18.3% |
| Return on assets (ROA) |
2.7%
|
-11.9%
|
23.3% |
| Current ratio |
172.2%
|
189.4%
|
455.7% |
| Return on equity (ROE) |
6.2%
|
-25.5%
|
32.1% |
| Change turnover |
59
|
-129
|
69 |
| Change turnover % |
23%
|
-34%
|
23% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.